Literature DB >> 17123604

Chemokine system and tissue infiltration in aggressive NK-cell leukemia.

Hideki Makishima1, Toshiro Ito, Kayoko Momose, Hideyuki Nakazawa, Shigetaka Shimodaira, Yuji Kamijo, Yozo Nakazawa, Naoaki Ichikawa, Mayumi Ueno, Hikaru Kobayashi, Kiyoshi Kitano, Hiroshi Saito, Kendo Kiyosawa, Fumihiro Ishida.   

Abstract

NK cell-type lymphoproliferative disease of granular lymphocytes can be subdivided into aggressive NK-cell leukemia (ANKL) and chronic NK-cell lymphocytosis (CNKL). Hepatosplenomegaly is observed in ANKL patients, and hepatic failure is a common cause of death. Significant numbers of ANKL cells were pathologically observed in sinusoidal and interlobular regions of the liver, and in the splenic red pulp. In our previous study, ANKL cells were simultaneously positive for CXCR1 and CCR5. So, in order to elucidate the mechanism in the systemic migration of ANKL cells, we investigated the expression of the corresponding chemokines in ANKL compared with CNKL. The serum level of IL-8, MIP-1alpha and MIP-1beta was significantly elevated in ANKL patients, and ANKL cells were highly positive for IL-8, RANTES, MIP-1alpha and MIP-1beta according to intracellular staining and RT-PCR. These chemokines were also positively stained in hepatocytes. The interaction between Fas and Fas ligand (FasL) is supposed to be one of the mechanisms for liver dysfunction in ANKL. The serum concentration of soluble FasL was significantly high in ANKL patients, and ANKL cells expressed FasL protein in the cytoplasm. These results suggest that the chemokine system plays an important role in the transmigration of FasL-expressing ANKL cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17123604     DOI: 10.1016/j.leukres.2006.10.020

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  12 in total

1.  Elevated serum granulysin and its clinical relevance in mature NK-cell neoplasms.

Authors:  Nodoka Sekiguchi; Naoko Asano; Toshiro Ito; Kayoko Momose; Masanobu Momose; Fumihiro Ishida
Journal:  Int J Hematol       Date:  2012-08-14       Impact factor: 2.490

Review 2.  Natural killer cell neoplasm: biology and pathology.

Authors:  Maria Francisca Ham; Young-Hyeh Ko
Journal:  Int J Hematol       Date:  2010-12-07       Impact factor: 2.490

3.  Close resemblance between chemokine receptor expression profiles of lymphoproliferative disease of granular lymphocytes and their normal counterparts in association with elevated serum concentrations of IP-10 and MIG.

Authors:  Kayoko Momose; Hideki Makishima; Toshiro Ito; Hideyuki Nakazawa; Shigetaka Shimodaira; Kendo Kiyosawa; Fumihiro Ishida
Journal:  Int J Hematol       Date:  2007-08       Impact factor: 2.490

4.  Involvement of ERK-1/2 in IL-21-induced cytokine production in leukemia cells and human monocytes.

Authors:  C F Fuqua; R Akomeah; J O Price; S E Adunyah
Journal:  Cytokine       Date:  2008-08-15       Impact factor: 3.861

5.  Networks inferred from biochemical data reveal profound differences in toll-like receptor and inflammatory signaling between normal and transformed hepatocytes.

Authors:  Leonidas G Alexopoulos; Julio Saez-Rodriguez; Benjamin D Cosgrove; Douglas A Lauffenburger; Peter K Sorger
Journal:  Mol Cell Proteomics       Date:  2010-05-10       Impact factor: 5.911

Review 6.  Aggressive mature natural killer cell neoplasms: from epidemiology to diagnosis.

Authors:  Margarida Lima
Journal:  Orphanet J Rare Dis       Date:  2013-07-01       Impact factor: 4.123

7.  Rare aggressive natural killer cell leukemia presented with bone marrow fibrosis - a diagnostic challenge.

Authors:  Dina S Soliman; Ahmad Al Sabbagh; Halima El Omri; Firyal A Ibrahim; Aliaa M Amer; Ivone B Otazu
Journal:  Springerplus       Date:  2014-07-29

8.  Flow Cytometric Immunophenotyping Is Sensitive for the Early Diagnosis of De Novo Aggressive Natural Killer Cell Leukemia (ANKL): A Multicenter Retrospective Analysis.

Authors:  Yi Li; Jia Wei; Xia Mao; Qingping Gao; Longlong Liu; Ping Cheng; Limei Liu; Xinhua Zhang; Ke Zhang; Jin Wang; Li Zhu; Jianfeng Zhou; Yicheng Zhang; Li Meng; Hanying Sun; Dengju Li; Mei Huang; Wei Huang; Jinniu Deng; Donghua Zhang
Journal:  PLoS One       Date:  2016-08-02       Impact factor: 3.240

Review 9.  CC chemokine receptor 5: the interface of host immunity and cancer.

Authors:  Carlos Eduardo Coral de Oliveira; Julie Massayo Maeda Oda; Roberta Losi Guembarovski; Karen Brajão de Oliveira; Carolina Batista Ariza; Jamil Soni Neto; Bruna Karina Banin Hirata; Maria Angelica Ehara Watanabe
Journal:  Dis Markers       Date:  2014-01-19       Impact factor: 3.434

10.  Absence of Association between CCR5 rs333 Polymorphism and Childhood Acute Lymphoblastic Leukemia.

Authors:  Carlos Eduardo Coral de Oliveira; Marla Karine Amarante; Aparecida de Lourdes Perim; Patricia Midori Murobushi Ozawa; Carlos Hiroki; Glauco Akelinghton Freire Vitiello; Roberta Losi Guembarovski; Maria Angelica Ehara Watanabe
Journal:  Adv Hematol       Date:  2014-04-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.